Metraipolis › archive › dc_cd88d58c65cc

Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42103949
DOI
10.1007/s00277-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-02T14:31:53.407Z
SHA-256 of the archived text
fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7
Stable URL of this page
https://metraipolis.com/documento/dc_cd88d58c65cc

How to cite

Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949 — Europe PMC (en), https://europepmc.org/article/MED/42103949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd88d58c65cc (Metraipolis archive dc_cd88d58c65cc, sha256 fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7)
BibTeX
@misc{dccd88d58c65cc,
  title = {Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL — Europe PMC PMID:42103949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42103949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd88d58c65cc; sha256 fbcd525c3c781eb6413d0865ced8a250336408e076e410871fd47495ef4d4fb7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42103949. Agents can read the archived copy with the MCP tool read_document.